Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 841 across all filing types
Latest filing 2025-04-02 Proxy Solicitation & In…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Kallelse till årsstämma i Orexo
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Kallelse till årsstämma' (Notice of Annual General Meeting) for Orexo AB. It contains the agenda, proposals for board elections, remuneration, and various corporate governance resolutions to be voted on by shareholders. This document is a classic proxy solicitation and information statement provided to shareholders ahead of the meeting to request their votes and provide necessary context for the meeting's agenda items.
2025-04-02 Swedish
Annual Report (ESEF) 2024
Annual Report (ESEF) Classification · 1% confidence FY 2024
2025-03-28 Swedish
Regulatory Filings 2025
Regulatory Filings Classification · 1% confidence The document is titled "Delårsrapport kv 4 2024, inkl bokslutskommuniké" which translates to "Interim Report Q4 2024, including year-end press release". It contains detailed financial tables covering Q4 and the full year (jan-dec), key performance indicators (Nettoomsättning, EBITDA, Resultat per aktie), and a table of contents listing sections like "Finansiell översikt" (Financial overview). This structure and content strongly indicate a comprehensive financial report for a period shorter than a full year (Q4), which aligns with the definition of an Interim/Quarterly Report. The length (over 116,000 characters) confirms it is the full report, not just an announcement (RPA/RNS). Therefore, the classification is IR (Interim Report).
2025-02-06 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report Q4 2024, incl. Full Year Report' and contains comprehensive financial statements, including income statements, balance sheet data, and management commentary (CEO comments). It provides detailed financial performance metrics for the quarter and full year, which aligns with the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report (RPA) because it contains the actual financial data and analysis. Q4 2024
2025-02-06 English
Kommuniké från Orexo AB:s extra bolagsstämma den 18 december 2024
AGM Information Classification · 1% confidence The document is titled "Kommuniké från Orexo AB:s extra bolagsstämma den 18 december 2024" (Communiqué from Orexo AB's Extraordinary General Meeting on December 18, 2024). The content explicitly details decisions made regarding the election of a new board member (Friedrich von Bohlen und Halbach) and the remuneration for the board, which are typical outcomes of a General Meeting. Since it reports the results of a shareholder vote/meeting concerning board composition and compensation, the most appropriate classification is AGM Information (AGM-R), as it directly relates to the proceedings and outcomes of a General Meeting. Although it is a communiqué, the subject matter is specific enough to warrant AGM-R over the general RPA or RNS.
2024-12-18 Swedish
Report from Orexo AB’s extraordinary general meeting, December 18 2024
AGM Information Classification · 1% confidence The document is explicitly titled "Report from Orexo AB's extraordinary general meeting, December 18 2024". It details resolutions passed at this meeting, specifically concerning the election of a new board member (Friedrich von Bohlen und Halbach) and related remuneration. This content directly relates to the governance and proceedings of a general meeting, which aligns best with the 'AGM Information' category, even though it is an 'extraordinary' meeting report rather than the annual one. The key elements are the meeting type and the resolutions passed regarding board composition.
2024-12-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.